Literature DB >> 33283175

Supramolecular nanostructures with tunable donor loading for controlled H2S release.

Yin Wang1, John B Matson1.   

Abstract

Hydrogen sulfide (H2S), an endogenously generated and regulated signaling gas, plays a vital role in a variety of (patho)physiological processes. In the past few years, different kinds of H2S-releasing compounds (often referred to as H2S donors) have been developed for H2S delivery, but it is still challenging to make H2S donors with tunable payloads in a simple and efficient manner. Herein, a series of peptide-H2S donor conjugates (PHDCs) with tunable donor loadings are designed for controlled H2S release. The PHDCs self-assemble into nanoribbons with different geometries in aqueous solution. Upon addition of cysteine, these nanostructures release H2S, delivering their payload into H9C2 cells, as visualized using an H2S-selective fluorescent probe. Beyond imaging, in vitro studies show that the ability of PHDCs to mitigate doxorubicin-induced cardiotoxicity in H9C2 cardiomyocytes depends on their nanostructures and H2S release profiles. This strategy may enable the development of sophisticated H2S-releasing biomaterials for drug delivery and regenerative medicine.

Entities:  

Keywords:  Controlled release; Drug delivery; Hydrogen Sulfide; Peptide; Self-assembly

Year:  2019        PMID: 33283175      PMCID: PMC7717493          DOI: 10.1021/acsabm.9b00768

Source DB:  PubMed          Journal:  ACS Appl Bio Mater        ISSN: 2576-6422


  38 in total

1.  Supramolecular Tuning of H2S Release from Aromatic Peptide Amphiphile Gels: Effect of Core Unit Substituents.

Authors:  Yun Qian; Kuljeet Kaur; Jeffrey C Foster; John B Matson
Journal:  Biomacromolecules       Date:  2019-01-24       Impact factor: 6.988

2.  Exogenous hydrogen sulfide protects against doxorubicin-induced inflammation and cytotoxicity by inhibiting p38MAPK/NFκB pathway in H9c2 cardiac cells.

Authors:  Runmin Guo; Keng Wu; Jingfu Chen; Liqiu Mo; Xiaoxiao Hua; Dongdan Zheng; Peixi Chen; Gang Chen; Wenming Xu; Jianqiang Feng
Journal:  Cell Physiol Biochem       Date:  2013-12-13

3.  Hydrogen sulfide protects H9c2 cells against doxorubicin-induced cardiotoxicity through inhibition of endoplasmic reticulum stress.

Authors:  Xiu-Yu Wang; Chun-Tao Yang; Dong-Dan Zheng; Li-Qiu Mo; Ai-Ping Lan; Zhan-Li Yang; Fen Hu; Pei-Xi Chen; Xin-Xue Liao; Jian-Qiang Feng
Journal:  Mol Cell Biochem       Date:  2011-12-28       Impact factor: 3.396

4.  The benefits of macromolecular hydrogen sulfide prodrugs.

Authors:  Luke A Connal
Journal:  J Mater Chem B       Date:  2018-11-05       Impact factor: 6.331

5.  pH-Controlled Hydrogen Sulfide Release for Myocardial Ischemia-Reperfusion Injury.

Authors:  Jianming Kang; Zhen Li; Chelsea L Organ; Chung-Min Park; Chun-Tao Yang; Armando Pacheco; Difei Wang; David J Lefer; Ming Xian
Journal:  J Am Chem Soc       Date:  2016-05-17       Impact factor: 15.419

6.  Production and physiological effects of hydrogen sulfide.

Authors:  Hideo Kimura
Journal:  Antioxid Redox Signal       Date:  2013-05-25       Impact factor: 8.401

7.  S-aroylthiooximes: a facile route to hydrogen sulfide releasing compounds with structure-dependent release kinetics.

Authors:  Jeffrey C Foster; Chadwick R Powell; Scott C Radzinski; John B Matson
Journal:  Org Lett       Date:  2014-02-27       Impact factor: 6.005

8.  Hydrogen sulfide cytoprotective signaling is endothelial nitric oxide synthase-nitric oxide dependent.

Authors:  Adrienne L King; David J Polhemus; Shashi Bhushan; Hiroyuki Otsuka; Kazuhisa Kondo; Chad K Nicholson; Jessica M Bradley; Kazi N Islam; John W Calvert; Ya-Xiong Tao; Tammy R Dugas; Eric E Kelley; John W Elrod; Paul L Huang; Rui Wang; David J Lefer
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-10       Impact factor: 11.205

Review 9.  Anthracycline cardiotoxicity in long-term survivors of childhood cancer.

Authors:  Rebecca E Scully; Steven E Lipshultz
Journal:  Cardiovasc Toxicol       Date:  2007       Impact factor: 3.231

Review 10.  New anthracycline antitumor antibiotics.

Authors:  F M Muggia; M D Green
Journal:  Crit Rev Oncol Hematol       Date:  1991       Impact factor: 6.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.